Geron | GERN - Despesas Operacionais





Despesas Operacionais Alterar Data
Amgen USD 11.69B 6.9B 2026-06
Bio Techne USD 235.92M 5.5M 2026-03
Cassava Sciences USD 11.17M 2.38M 2026-03
Cytokinetics USD 207.8M 7.22M 2026-06
Exelixis USD 380.28M 20.8M 2026-06
Genmab DKK 748M 77M 2026-06
Geron USD 52.07M 6.73M 2026-03
Gilead Sciences USD 3.95B 19.57B 2026-06
Incyte USD 973.64M 4.65B 2026-06
MacroGenics USD 42.87M 21.68M 2026-06
Novartis USD 10.2B 912M 2026-06
Novavax USD 126.2M 23.62M 2025-12